Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Virological Efficacy and Safety of Etravirine Plus 2 Active Nucleos(t)Ide Reverse-transcriptase Inhibitors (NRTIs) in HIV-1-infected Patients

NCT01437241 is registered in ClinicalTrials.gov with Hospitales Universitarios Virgen del Rocío as lead sponsor.

NCT NCT01437241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01437241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Virological Efficacy and Safety of Etravirine Plus 2 Active Nucleos(t)Ide Reverse-transcriptase Inhibitors (NRTIs) in HIV-1-infected Patients
Lead sponsor
Hospitales Universitarios Virgen del Rocío
Phase
Observational
Overall status
Completed
Start date
January 31, 2009
Completion date
September 30, 2011
Enrollment
175 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection